Abstract
The objective of this study was to evaluate the efficacy of low-dose (0.2 mg/kg) methotrexate (MTX) in the treatment of children with oligoarticular juvenile idiopathic arthritis (JIA) who do not respond to nonsteroidal anti-inflammatory drugs (NSAIDs) and repeated intra-articular corticosteroid (IA) injections. Nineteen consecutive patients (age: 2–14 years, 18 females) with oligoarticular JIA were studied prospectively. Sixteen had a persistent course and three had an extended course of the disease. Patients were defined as nonresponders to IA injections if the duration of improvement following two consecutive injections was less than 4 weeks. These patients were offered low-dose oral MTX, administered once a week for at least 6 months. Of the 19 patients in this series, 2 responded to NSAIDs alone. Forty-eight IA injections were given to 17 patients; 11 (64%) of them did not respond to this treatment. Nine of the nonresponders were treated with low-dose MTX for a median duration of 15±3.8 months. Except for one patient with an extended disease course, all responded very well to treatment and went into remission after a median of 6.4±2.9 months, and none required additional IA injections after initiation of MTX treatment. Low-dose oral MTX appears to be very effective in the management of children with oligoarticular JIA, who are unresponsive to IA injections.
Similar content being viewed by others
References
Petty RS, Cassidy JT (2001) The juvenile idiopathic arthritis; comparison of the ACR, EULAR, and ILAR criteria. In: Cassidy JT 3rd (ed) Textbook of pediatric rheumatology. W.B. Saunders, Philadelphia, p 214
Brewer EJ Jr, Bass J, Baum J et al (1977) Current proposed revision JRA criteria. Arthritis Rheum 20 [Suppl]:195
European League Against Rheumatism EULAR Bulletin No.4 (1977) Nomenclature and classification of arthritis in children. Basel, National Zeitung AG
Petty RE, Southwood TR, Baum J et al (1998) Revision of the proposed classification criteria for juvenile idiopathic arthritis, Durban 1997. J Rheumatol 25:1991–1994
Cron RQ, Sharma S, Sherry DD (1999) Current treatment by United States and Canadian pediatric rheumatologists. J Rheumatol 26:2036–2038
Dent PB, Walker N (1998) Intra-articular corticosteroids in the treatment of juvenile rheumatoid arthritis. Curr Opin Rheumatol 10:475–480
Padeh S, Paswell JH (1998) Intraarticular corticosteroid injection in the management of children with chronic arthritis. Arthritis Rheum 41:1210–1214
Neidel J, Boehnke M, Kuster RM (2002) The efficacy and safety of intraarticular corticosteroid therapy for coxitis in juvenile rheumatoid arthritis. Arthritis Rheum 46:1620–1628
Breit W, Frosch M, Meyer U, Heinecke A, Ganser G (2000) A subgroup-specific evaluation of the efficacy of intraarticular triamcinolone hexacetonide for the management of childhood arthritis. J Rheumatol 27:2696–2702
Cassidy JT, Bole GG (1966) Cutaneous atrophy secondary to intra-articular corticosteroid administration. Ann Intern Med 65:1008–1018
Gilsanz V, Brenstein BH (1984) Joint calcification following intra-articular corticosteroid therapy. Radiology 151:647–649
Balogh Z, Ruzsonoyi E (1988) Triamcinolone hexacetonide versus betamethasone. Scand J Rheumatol Suppl 67:80–82
Bird HA, Ring EFJ, Bacon PA (1979) A thermographic and clinical comparison of three intra-articular steroid preparations in rheumatoid arthritis. Ann Rheum Dis 38:36–39
Wallace CA (1998) The use of methotrexate in childhood rheumatic diseases (review). Arthritis Rheum 41:381–391
O’Dell JR (2004) Therapeutic strategies for rheumatoid arthritis. N Engl J Med 350:2591–2602
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Brik, R., Gepstein, V. & Berkovitz, D. Low-dose methotrexate treatment for oligoarticular juvenile idiopathic arthritis nonresponsive to intra-articular corticosteroids. Clin Rheumatol 24, 612–614 (2005). https://doi.org/10.1007/s10067-005-1116-7
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10067-005-1116-7